Eagle Asset Management Inc Bio Techne Corp Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Eagle Asset Management Inc holds 299,707 shares of TECH stock, worth $21.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
299,707
Previous 308,837 2.96%
Holding current value
$21.9 Million
Previous $22.1 Million 8.23%
% of portfolio
0.14%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$70.96 - $82.35 $647,864 - $751,855
-9,130 Reduced 2.96%
299,707 $23.9 Million
Q2 2024

Aug 12, 2024
SELL
$62.12 - $84.15 $43.6 Million - $59.1 Million
-702,228 Reduced 69.45%
308,837 $22.1 Million
Q1 2024

May 09, 2024
BUY
$65.98 - $77.09 $5.26 Million - $6.14 Million
79,699 Added 8.56%
1,011,065 $71.2 Million
Q4 2023

Feb 12, 2024
BUY
$52.83 - $78.22 $8.64 Million - $12.8 Million
163,522 Added 21.3%
931,366 $71.9 Million
Q3 2023

Nov 13, 2023
BUY
$67.52 - $89.42 $232,133 - $307,425
3,438 Added 0.45%
767,844 $52.3 Million
Q2 2023

Aug 09, 2023
SELL
$73.76 - $85.98 $977,024 - $1.14 Million
-13,246 Reduced 1.7%
764,406 $62.4 Million
Q1 2023

May 08, 2023
BUY
$71.62 - $86.62 $745,134 - $901,194
10,404 Added 1.36%
777,652 $57.7 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $51.4 Million - $224 Million
637,162 Added 489.8%
767,248 $63.6 Million
Q3 2022

Nov 07, 2022
BUY
$282.54 - $391.85 $544,172 - $754,703
1,926 Added 1.5%
130,086 $36.9 Million
Q2 2022

Aug 10, 2022
BUY
$322.67 - $449.65 $743,431 - $1.04 Million
2,304 Added 1.83%
128,160 $44.4 Million
Q1 2022

May 12, 2022
BUY
$353.85 - $487.79 $73,954 - $101,948
209 Added 0.17%
125,856 $54.5 Million
Q4 2021

Feb 11, 2022
BUY
$456.15 - $525.06 $352,147 - $405,346
772 Added 0.62%
125,647 $63.9 Million
Q3 2021

Nov 10, 2021
SELL
$444.87 - $538.88 $25.2 Million - $30.5 Million
-56,638 Reduced 31.2%
124,875 $60.5 Million
Q2 2021

Aug 11, 2021
BUY
$387.35 - $450.26 $46 Million - $53.5 Million
118,718 Added 189.06%
181,513 $81.7 Million
Q1 2021

May 14, 2021
BUY
$314.62 - $411.0 $2.18 Million - $2.84 Million
6,919 Added 12.38%
62,795 $24.4 Million
Q4 2020

Feb 12, 2021
SELL
$246.9 - $321.87 $3.41 Million - $4.45 Million
-13,810 Reduced 19.82%
55,876 $17.7 Million
Q3 2020

Nov 12, 2020
SELL
$232.22 - $282.96 $144,905 - $176,567
-624 Reduced 0.89%
69,686 $17.2 Million
Q2 2020

Aug 12, 2020
BUY
$185.43 - $279.56 $236,237 - $356,159
1,274 Added 1.85%
70,310 $17.8 Million
Q1 2020

May 11, 2020
BUY
$161.17 - $221.51 $2.86 Million - $3.94 Million
17,776 Added 34.68%
69,036 $13.1 Million
Q4 2019

Feb 07, 2020
BUY
$189.68 - $222.09 $526,172 - $616,077
2,774 Added 5.72%
51,260 $11.3 Million
Q3 2019

Nov 04, 2019
BUY
$183.56 - $216.72 $159,880 - $188,763
871 Added 1.83%
48,486 $9.49 Million
Q2 2019

Aug 05, 2019
SELL
$188.72 - $215.43 $192,683 - $219,954
-1,021 Reduced 2.1%
47,615 $9.93 Million
Q1 2019

May 01, 2019
BUY
$136.09 - $200.44 $52,666 - $77,570
387 Added 0.8%
48,636 $9.66 Million
Q4 2018

Feb 11, 2019
SELL
$132.75 - $203.8 $1.57 Million - $2.41 Million
-11,827 Reduced 19.69%
48,249 $6.98 Million
Q3 2018

Nov 08, 2018
BUY
$147.44 - $204.11 $141,689 - $196,149
961 Added 1.63%
60,076 $12.3 Million
Q2 2018

Aug 07, 2018
BUY
$144.9 - $165.58 $399,634 - $456,669
2,758 Added 4.89%
59,115 $8.75 Million
Q1 2018

May 09, 2018
SELL
$131.46 - $151.04 $63,100 - $72,499
-480 Reduced 0.84%
56,357 $8.51 Million
Q4 2017

Feb 09, 2018
BUY
$121.17 - $134.75 $102,025 - $113,459
842 Added 1.5%
56,837 $7.44 Million
Q3 2017

Nov 09, 2017
BUY
$113.59 - $123.78 $6.36 Million - $6.93 Million
55,995
55,995 $6.87 Million

Others Institutions Holding TECH

# of Institutions
602
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email